Back to the open positions
January 13, 2023 - Hamden, Connecticut
The first shipment of Shylicine intended for the UAE Clinical trial is now, officially, on the way to Dubai.
This is a significant accomplishment for our team and evidence of our capacity to quickly reproduce a high-quality drug for human ingestion.
We congratulate the entire team in Spain, Hungary and the US for a job well done despite these extremely trying times.